Efficacy of pembrolizumab treatment in mucosal melanoma
The Medicines Adaptive Pathways to Patients (MAPPs) and its importance in oncology
Benefits and risks of treatment with ipilimumab after complete resection of Stage III melanoma
What to do with BRAF-mutant melanoma patients who have a poor prognosis?
Next steps for lymphangiogenesis in melanoma